Researchers at Fred Hutchinson Cancer Center have developed a new hybridoma cell line that expresses mouse anti-human NKG2D antibodies. Reference: Bauer, et al., Science. 1999; 285(5428):727-9.

Researchers at Fred Hutchinson Cancer Center have developed a new hybridoma cell line that expresses mouse anti MICA/MICB antibodies. Reference: Bauer, et al., Science. 1999; 285(5428):727-9.

Recently published research* has established the ability of Neowater® to enhance the various processes involved in the production of pure human monoclonal antibodies by refining the standard hybridoma ...

The maturation of proteomics as a separate experimental field from genomics has highlighted the importance of obtaining information concerning a given protein’s activation state. This information can ...

The increase in the utilization of monoclonal antibodies as therapeutics over the past two decades has been remarkable, with over 80 mAbs approved for use. The quick pace of clinical studies and ...

UI’s Developmental Studies Hybridoma Bank will use a $3.4 million grant from the National Institutes of Health to consolidate its various labs and offices into a lab twice as large on the north wing ...

This article discusses how Cyto-Mine ® can be used to screen complex populations of primary B cells and hybridomas by employing a miniaturized, high-throughput, homogeneous secretion assay for the ...

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...